COVID-19 test solutions
(CE IVD & RUO)

Throughout the pandemic, GeneFirst has committed to being a proactive developer and supplier of COVID-19 RT-PCR kits, with the launch of CE-IVD kits for the detection of SARS-CoV-2 and others commonly circulating viral pathogens. In addition, GeneFirst recently launched a single tube multiplex assay for the detection of variants of concern currently in circulation, called the COVID-19 Variant Detection Kit.

Learn more

---

Oncoplex
Mutation Detection

Incorporating GeneFirst Multiplex Mutation Detection (MMD) technology, Oncoplex Mutation Detection kits are highly sensitive, allowing for detection of rare mutations against a high background of normal, non-mutated genomic DNA. For research purposes only.

learn more

---

Papilloplex
​High Risk HPV

The GeneFirst Papilloplex® High Risk HPV Test was designed to meet medical needs by targeting 14 HPV genotypes to better stratify risk and disease progression. This test, based on GeneFirst's proprietary Multiplex Probe Amplification (MPA) technology, helps to better understand the infection of specific HPV genotypes for the development of strategies to improve the prevention and management of cervical cancer.

learn more

---

XceloSeq®

• Targeted cfDNA Enrichment Kits:
  NGS library preparation kits for cancer detection from liquid biopsies.
  ​Learn more...
  
  
• ​Targeted RNA Enrichment Kits:
  NGS library preparation kits for cancer detection from FFPE RNA samples.
  ​Learn more...
  ​
• Indexing Kits: 
  Indexing primers for sample multiplexing with XCeloSeq library preparation kits.
  ​Learn more...

Viral-Prep DNA Extraction Kit
​
The Viral Prep Adem-Kit extraction kit allows the extraction of nucleic acids (single-stranded, double-stranded DNA or RNA) from samples such as whole blood, serum, plasma, biopsies, respiratory samples, swab nasopharyngeal and faeces with optimal efficiency to ensure their purity and their use in molecular biology.

Learn more